Evaluation of the anti-osteoarthritic effects and mechanisms of Cissus quadrangularis extract containing quercetin and isorhamnetin in a rat model of monosodium iodoacetate-induced osteoarthritis

DOI: https://doi.org/10.29219/fnr.v69.12173
Keywords: Osteoarthritis, Cissus quadrangularis, quercetin, isorhamnetin, inflammation, cartilage protection, matrix metalloproteinases

Abstract

Background: Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation, subchondral bone erosion, and chronic inflammation. Current treatments primarily focus on symptom relief and have significant side effects, highlighting the need for safer, more effective alternatives. Cissus quadrangularis extract (CQE), containing bioactive flavonoids quercetin and isorhamnetin, has shown potential anti-inflammatory and cartilage-protective properties.

Objective: This study aimed to investigate the anti-osteoarthritic effects and mechanisms of action of CQE in a monosodium iodoacetate (MIA)-induced OA rat model.

Design: Sprague-Dawley (SD) rats were induced with OA through intra-articular injection of MIA and treated with CQE at doses of 30, 50, and 100 mg/kg body weight (BW)/day. The effects of CQE on knee joint damage, subchondral bone erosion, cartilage structure, proteoglycan content, and the expression of inflammatory mediators and matrix metalloproteinases (MMPs) were assessed using micro-computed tomography (micro-CT), histological staining, immunofluorescence, and real-time reverse transcription-polymerase chain reaction (RT-PCR).

Results: CQE significantly mitigated knee joint damage, reduced subchondral bone erosion, and enhanced bone volume and trabecular structure in MIA-induced OA rats. It also preserved cartilage integrity by maintaining proteoglycan content and the expression of collagen type II alpha 1 (COL2A1) and aggrecan. Moreover, CQE suppressed the mRNA expression of inflammatory mediators [inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and 5-lipoxygenase (5-LOX)], pro-inflammatory cytokines [interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α)], and MMPs (MMP-2, MMP-3, MMP-9, and MMP-13), indicating strong anti-inflammatory and cartilage-protective effects.

Conclusions: CQE exhibits significant therapeutic potential in managing OA by targeting multiple aspects of disease progression, including inflammation, cartilage degradation, and bone erosion. Further research is needed to explore long-term efficacy, safety, and the molecular mechanisms of CQE, as well as to validate these findings in human clinical trials

Downloads

Download data is not yet available.

References


1.
Englund M. Osteoarthritis, part of life or a curable disease? A bird’s-eye view. J Intern Med 2023; 293(6): 681–93. doi: 10.1111/joim.13634


2.
Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol 2016; 12(7): 412–20. doi: 10.1038/nrrheum.2016.65


3.
Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-art management of knee osteoarthritis. World J Clin Cases 2015; 3(2): 89–101. doi: 10.12998/wjcc.v3.i2.89


4.
Bjordal JM, Klovning A, Ljunggren AE, Slørdal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007; 11(2): 125–38. doi: 10.1016/j.ejpain.2006.02.013


5.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086. doi: 10.1136/bmj.c7086


6.
Buddhadev S, Buddhadev S. A review update on plant Cissus Quadrangularis L. Punarnav 2014; 2(4): 1–10.


7.
Hamid HS, Patil S. A phytochemical and pharmacological review of an Indian plant: Cissus Quadrangularis. Med Sci Forum 2023; 21(1): 20. doi: 10.3390/ECB2023-14557


8.
Bafna PS, Patil PH, Maru SK, Mutha RE. Cissus quadrangularis L: a comprehensive multidisciplinary review. J Ethnopharmacol 2021; 279: 114355. doi: 10.1016/j.jep.2021.114355


9.
Oben J, Kuate D, Agbor G, Momo C, Talla X. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis 2006; 5: 24. doi: 10.1186/1476-511X-5-24


10.
Lee HJ, Lee D-R, Choi B-K, Park S-B, Jin Y-Y, Yang SH, et al. Cissus quadrangularis extracts decreases body fat through regulation of fatty acid synthesis in high-fat diet-induced obese mice. J Appl Biol Chem 2016; 59(1): 49–56. doi: 10.3839/jabc.2016.010


11.
Kuate D, Nash RJ, Bartholomew B, Penkova Y. The use of Cissus quadrangularis (CQR-300) in the management of components of metabolic syndrome in overweight and obese participants. Nat Prod Commun 2015; 10(7): 1281–6. doi: 10.1177/1934578X1501000737


12.
Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis 2008; 7: 12. doi: 10.1186/1476-511X-7-12


13.
Nash R, Azantsa B, Kuate D, Singh H, Oben J. The use of a stem and leaf aqueous extract of Cissus quadrangularis (CQR-300) to reduce body fat and other components of metabolic syndrome in overweight participants. J Altern Complement Med 2019; 25(1): 98–106. doi: 10.1089/acm.2018.0016


14.
Stohs SJ, Ray SD. A review and evaluation of the efficacy and safety of Cissus quadrangularis extracts. Phytother Res 2013; 27(8): 1107–14. doi: 10.1002/ptr.4846


15.
Kothari SC, Shivarudraiah P, Venkataramaiah SB, Koppolu KP, Gavara S, Jairam R, et al. Safety assessment of Cissus quadrangularis extract (CQR-300): subchronic toxicity and mutagenicity studies. Food Chem Toxicol 2011; 49(12): 3343–57. doi: 10.1016/j.fct.2011.09.029


16.
Bhujade AM, Talmale S, Kumar N, Gupta G, Reddanna P, Das SK, et al. Evaluation of Cissus quadrangularis extracts as an inhibitor of COX, 5-LOX, and proinflammatory mediators. J Ethnopharmacol 2012; 141(3): 989–96. doi: 10.1016/j.jep.2012.03.044


17.
Kanwar JR, Samarasinghe RM, Kumar K, Arya R, Sharma S, Zhou SF, et al. Cissus quadrangularis inhibits IL-1β induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling. Drug Des Devel Ther 2015; 9: 2927–40. doi: 10.2147/DDDT.S77369


18.
Panthong A, Supraditaporn W, Kanjanapothi D, Taesotikul T, Reutrakul V. Analgesic, anti-inflammatory and venotonic effects of Cissus quadrangularis Linn. J Ethnopharmacol 2007; 110(2): 264–70. doi: 10.1016/j.jep.2006.09.018


19.
Kumar R, Gupta YK, Singh S, Arunraja S. Cissus quadrangularis attenuates the adjuvant induced arthritis by down regulating pro-inflammatory cytokine and inhibiting angiogenesis. J Ethnopharmacol 2015; 175: 346–55. doi: 10.1016/j.jep.2015.08.058


20.
Lakshmanan DK, Ravichandran G, Elangovan A, Jeyapaul P, Murugesan S, Thilagar S. Cissus quadrangularis (veldt grape) attenuates disease progression and anatomical changes in mono sodium iodoacetate (MIA)-induced knee osteoarthritis in the rat model. Food Funct 2020; 11(9): 7842–55. doi: 10.1039/d0fo00992j


21.
Kim D, Lee D, Oh D, Jeong HC, Lee SJ, Sohn J, et al. A mixture containing fermented Achyranthes japonica nakai ameliorates osteoarthritis in knee joints of monoiodoacetate-injected rats. J Med Food 2020; 23(8): 811–17. doi: 10.1089/jmf.2019.4552


22.
Choi YJ, Jung JI, Bae J, Lee JK, Kim EJ. Evaluating the anti-osteoarthritis potential of standardized Boswellia serrata gum resin extract in alleviating knee joint pathology and inflammation in osteoarthritis-induced models. Int J Mol Sci 2024; 25(6): 3218. doi: 10.3390/ijms25063218


23.
Udo M, Muneta T, Tsuji K, Ozeki N, Nakagawa Y, Ohara T, et al. Monoiodoacetic acid induces arthritis and synovitis in rats in a dose- and time-dependent manner: proposed model-specific scoring systems. Osteoarthritis Cartilage 2016; 24(7): 1284–91. doi: 10.1016/j.joca.2016.02.005


24.
Jung JI, Lee HS, Jeon YE, Kim SM, Hong SH, Moon JM, et al. Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague-Dawley rats. Inflammopharmacology 2021; 29(5): 1475–86. doi: 10.1007/s10787-021-00870-3


25.
Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010; 18(Suppl. 3): S17–23. doi: 10.1016/j.joca.2010.05.025


26.
Gupta PK, Das AK, Chullikana A, Majumdar AS. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther 2012; 3(4): 25. doi: 10.1186/scrt116


27.
Gambari L, Cellamare A, Grassi F, Grigolo B, Panciera A, Ruffilli A, et al. Overview of anti-inflammatory and anti-nociceptive effects of polyphenols to halt osteoarthritis: from preclinical studies to new clinical insights. Int J Mol Sci 2022; 23(24): 15861. doi: 10.3390/ijms232415861


28.
Gong G, Guan YY, Zhang ZL, Rahman K, Wang SJ, Zhou S, et al. Isorhamnetin: a review of pharmacological effects. Biomed Pharmacother 2020; 128: 110301. doi: 10.1016/j.biopha.2020.110301


29.
Mok SW, Fu SC, Cheuk YC, Chu IM, Chan KM, Qin L, et al. Intra-articular delivery of quercetin using thermosensitive hydrogel attenuate cartilage degradation in an osteoarthritis rat model. Cartilage 2020; 11(4): 490–9. doi: 10.1177/1947603518796550


30.
Mao H, Feng Y, Feng J, Yusufu Y, Sun M, Yang L, et al. Quercetin-3-O-β-D-glucuronide attenuates osteoarthritis by inhibiting cartilage extracellular matrix degradation and inflammation. J Orthop Translat 2024; 45: 236–46. doi: 10.1016/j.jot.2024.01.007


31.
Tsai SW, Lin CC, Lin SC, Wang SP, Yang DH. Isorhamnetin ameliorates inflammatory responses and articular cartilage damage in the rats of monosodium iodoacetate-induced osteoarthritis. Immunopharmacol Immunotoxicol 2019; 41(4): 504–12. doi: 10.1080/08923973.2019.1641723


32.
Wang H, Yan Y, Pathak JL, Hong W, Zeng J, Qian D, et al. Quercetin prevents osteoarthritis progression possibly via regulation of local and systemic inflammatory cascades. J Cell Mol Med 2023; 27(4): 515–28. doi: 10.1111/jcmm.17672


33.
Wong SK, Chin KY, Ima-Nirwana S. Quercetin as an agent for protecting the bone: a review of the current evidence. Int J Mol Sci 2020; 21(17): 6448. doi: 10.3390/ijms21176448


34.
Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals (Basel) 2023; 16(7): 1020. doi: 10.3390/ph16071020


35.
Ahn HJ, You HJ, Park MS, Li Z, Choe D, Johnston TV, et al. Microbial biocatalysis of quercetin-3-glucoside and isorhamnetin-3-glucoside in Salicornia herbacea and their contribution to improved anti-inflammatory activity. RSC Adv 2020; 10(9): 5339–50. doi: 10.1039/c9ra08059g


36.
Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol 2006; 72(8): 1010–21. doi: 10.1016/j.bcp.2006.07.016
Published
2025-04-16
How to Cite
Choi , Y.-J., Jung , J. I., Bae , J., Lee , J. K., & Kim , E. J. (2025). Evaluation of the anti-osteoarthritic effects and mechanisms of Cissus quadrangularis extract containing quercetin and isorhamnetin in a rat model of monosodium iodoacetate-induced osteoarthritis. Food & Nutrition Research, 69. https://doi.org/10.29219/fnr.v69.12173
Issue
Vol 69 (2025)
Section
Original Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright of their work, with first publication rights granted to SNF Swedish Nutrition Foundation. Read the full Copyright- and Licensing Statement.

 

 

Crossref
Scopus
Google Scholar
Europe PMC